0001179110-11-005180.txt : 20110317
0001179110-11-005180.hdr.sgml : 20110317
20110317191039
ACCESSION NUMBER: 0001179110-11-005180
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110315
FILED AS OF DATE: 20110317
DATE AS OF CHANGE: 20110317
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brinkley David L
CENTRAL INDEX KEY: 0001302445
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30319
FILM NUMBER: 11696342
MAIL ADDRESS:
STREET 1: 901 GATEWAY BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: THERAVANCE INC
CENTRAL INDEX KEY: 0001080014
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943265960
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 901 GATEWAY BLVD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 6508086000
MAIL ADDRESS:
STREET 1: 901 GATEWAY BLVD
CITY: S. SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: ADVANCED MEDICINE INC
DATE OF NAME CHANGE: 20000302
4
1
edgar.xml
FORM 4 -
X0303
4
2011-03-15
0
0001080014
THERAVANCE INC
THRX
0001302445
Brinkley David L
THERAVANCE, INC.
901 GATEWAY BOULEVARD
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Head of Business Dev.
Common Stock
2011-03-15
4
M
0
38271
8.53
A
136650
D
Common Stock
2011-03-15
4
M
0
3290
3.10
A
139940
D
Common Stock
2011-03-15
4
M
0
3931
3.10
A
143871
D
Common Stock
2011-03-15
4
S
0
45492
22.08
D
98379
D
Common Stock
2011-03-16
4
M
0
2100
3.10
A
100479
D
Common Stock
2011-03-16
4
S
0
2100
22.02
D
98379
D
Stock Option (Right to Buy)
8.53
2011-03-15
4
M
0
38271
0
D
2012-02-24
Common Stock
38271
0
D
Stock Option (Right to Buy)
3.10
2011-03-15
4
M
0
3290
0
D
2013-01-24
Common Stock
3290
0
D
Stock Option (Right to Buy
3.10
2011-03-15
4
M
0
3931
0
D
2013-01-24
Common Stock
3931
4752
D
Stock Option (Right to Buy)
3.10
2011-03-16
4
M
0
2100
0
D
2013-01-24
Common Stock
2100
2652
D
This transaction was executed in multiple trades at prices ranging from $22.00 to $22.24. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $22.00 to $22.08. The price reported above reflects the weighted average sale price.
Immediately exercisable
Dispositions made pursuant to a plan intended to comply with Rule 10b5-1(c).
David Brinkley
2011-03-17